Are we making efficient use of clopidogrel?
نویسندگان
چکیده
منابع مشابه
Are we making efficient use of clopidogrel?
Blood platelets play a major role in the occurrence of thrombotic complications after percutaneous coronary interventions (PCI). Introduction of the thienopyridine drug ticlopidine as an adjunctive antiplatelet therapy has considerably improved the outcome of patients who undergo PCI. Thienopyridines act via blockade of one (P2Y12) of the three adenosine 50-diphosphate (ADP) receptors, reducing...
متن کاملClopidogrel in acute coronary syndromes: where are we now?
Acute coronary syndromes (ACS) are the most common cause of death worldwide. In the United States, over 1,500,000 patients with an ACS are discharged annually (1). ACS is caused by disruption of an atherosclerotic plaque with superimposed thrombotic occlusion of the coronary artery, resulting in myocardial ischaemia or infarction. Platelets play a central role in the initiation and propagation ...
متن کاملPersonalized approaches to clopidogrel therapy: are we there yet?
Clopidogrel is one of the most commonly prescribed medications worldwide. Recent advisories from the US Food and Drug Administration have drawn attention to the possibility of personalized decision-making for people who are candidates for clopidogrel. As is the case with antihypertensives, statins, and warfarin, common genetic sequence variants can influence clopidogrel metabolism and its effec...
متن کاملTuberculosis: are we making it incurable?
Tuberculosis (TB) is most probably the disease that has caused more damage to the human species throughout its history in terms of number of patients and, above all, death toll. There have been thousands of years spent fighting against Mycobacterium tuberculosis in which the human species could only rely on the efficiency of the immune system [1]. We must recall its importance as, in the pre-an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2004
ISSN: 0195-668X
DOI: 10.1016/j.ehj.2004.02.005